Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy,
such as etoposide, work in different ways to stop the growth of tumor cells, either by
killing the cells or by stopping them from dividing. Giving gefitinib together with etoposide
may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving gefitinib together with etoposide
works in treating patients with advanced prostate cancer that did not respond to hormone
therapy.